Brian Stutland Sees Unusual Options Activity In Juno Therapeutics

Brian Stutland spoke on CNBC's "Options Action" about a bullish options activity in Juno Therapeutics Inc JUNO.

He said that traders were selling puts and buying calls on a day when the stock spiked around 20 percent. Around 750 contracts of the September 42 puts were sold for $2.20 on Tuesday. There was also a big volume in the September 42.50 calls. Over 1,200 contracts were traded in the strike.

Stutland explained it seems that Gilead Sciences, Inc.'s GILD acquisition of Kite Pharma Inc KITE has increased the value of t-cell research.